Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pest-Vac
- Development stage
- Unknown
- Lead developer
- FARVET
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Pest-Vac is a live attenuated veterinary vaccine developed by FARVET for the active immunization of swine against Classical Swine Fever (CSF), also known as hog cholera. The vaccine utilizes the Chinese strain (C-strain) of the Classical Swine Fever virus, which has been modified through serial passage to lose its virulence while retaining the ability to replicate within the host. This replication stimulates a robust and long-lasting immune response, including both humoral (antibody) and cellular components, without inducing clinical disease. Pest-Vac is primarily used in endemic regions to prevent outbreaks of CSF, a highly contagious and economically devastating viral disease in the porcine industry. It is typically administered to healthy piglets and breeding stock via intramuscular injection.
- Brand names
- Pest-Vac
- Other names
- Vacuna viva porcinalive swine vaccinelive attenuated swine vaccine
02
Targets
CSFV (Classical swine fever virus)
Beyond the preview
Go deeper on Pest-Vac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pest-Vac.